Parexel Employee Insights

Ste Nadin, Vice President Enterprise Architecture, discuss the value of architecture within the industry and Parexel Informatics, and the type of person who would fit well in the team.

Simon Sering, Director for Software Engineering talks about his role within Parexel Informatics

Ste Nadin shares why he likes the work he does and why he likes working for Parexel Informatics

Simon Shering, Director of Software Engineering, talks about what makes it a great time to be joining Parexel Informatics.

Ste Nadin, Vice President of Enterprise Architecture, discusses our sector and the important role Architects play within Parexel.

Simon Shering, Director of Software Engineering, talks about why he likes working for Parexel and how he achieves a work life balance.

Parexel experts discuss the current state of treatment for Duchenne Muscular Dystrophy as a supporter of the Jett Foundation’s virtual World Duchenne Awareness Day celebration, taking place Sept. 7-11

Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi

Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi

Parexel’s Leanne Larson, Corporate VP and WW Head, Real-world Evidence speaks with Deborah Collyar, cancer survivor and President of Advocates in Research about the importance of Real-world Evidence (

At Parexel, we are Project Leaders, not managers. During these unprecedented times, we have forged ahead—innovating and accelerating our impact. During this presentation, we'll share with you the wa

Sy Pretorius, EVP and Chief Medical & Scientific Officer, Parexel and Gadi Saarony, CEO, Advarra discuss how industry-leading innovations help to reduce the time and cost of development, minimize the

Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-world Evidence and FDA/Regulatory expertise to develop and execute a Synthet

Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-world Evidence and FDA/Regulatory expertise to develop and execute a Synthet

Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-World Evidence and FDA/Regulatory expertise to develop and execute a Synthet

Parexel's #KeepingPatientsFirst is a real world evidence research platform powered by Microsoft Azure. It provides patients and physicians collective knowledge surrounding COVID-19, and the promising

Parexel proudly recognizes the significant contributions of our teams on the front lines for keeping patients first during COVID-19.

Parexel’s Global Head of Parexel FSP, Chris Baker and Neil Berger, VP, Enterprise Account Leader discuss how our award-winning client service, innovation, therapeutic expertise and patient-centric sol

Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi